TECH & INNOVATION

All Eyes on Palatin Technologies as Major Obesity Trial Results

All Eyes on Palatin Technologies as Major Obesity Trial Results Near

Palatin Technologies has completed its closely watched Phase 2 BMT-801 clinical trial, with results expected before the end of March 2025. The study, which drew unexpectedly strong interest from patients, enrolled 113 participants—nearly double its initial target of 60—across four U.S. clinical sites.

Recommended Stories